Form 8.3 - HORIZON THERAPEUTICS PLC

Barclays PLC
06 June 2023
 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:

 

Barclays PLC.

(b)

Owner or controller of interest and short

 

 

positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

HORIZON THERAPEUTICS PLC

 

relevant securities this form relates:

(d)

If an exempt fund manager connected with an

 

 

offeror/offeree, state this and specify identity of

 

offeror/offeree:

(e)

Date position held/dealing undertaken:

05 Jun 2023

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 

 

 

disclosures in respect of any other party to the offer?

 

 

2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

 

to which the disclosure relates following the dealing(if any)

 

Class of relevant security:

$0.001 ordinary shares

 

Interests

Short Positions

 

Number

(%)

Number

(%)

(1)

Relevant securities owned

 

 

 

 

 

and/or controlled:

 

 

1,087,377

0.48%

678,970

0.30%

(2)

Cash-settled derivatives:

 

 

 

 

 

and/or controlled:

 

 

140,756

0.06%

98,064

0.04%

(3)

Stock-settled derivatives (including options)

 

 

 

 

 

and agreements to purchase/sell:

 

 

1,422,500

0.62%

936,400

0.41%

 

 

 

 

 

 

 

 

 

TOTAL:

 

 

2,650,633

1.16%

1,713,434

0.75%

(b)

Rights to subscribe for new securities (including directors and other executive

 

 

options)

 

 

 

 

 

 

Class of relevant security in relation to

 

 

 

 

which subscription right exists

 

 

 

 

Details, including nature of the rights

 

 

 

 

concerned and relevant percentages:

 

 

 

 

3.

DEALINGS (IF ANY) BY THE EXEMPT PRINCIPAL TRADER

(a)

Purchases and sales

 

 

 

 

 

Class of relevant

Purchase/sale

Number of

Price per unit

security

 

securities

 

$0.001 ordinary shares

Purchase

96

99.8275  USD

$0.001 ordinary shares

Purchase

27,501

99.8157  USD

$0.001 ordinary shares

Purchase

4,531

99.8554  USD

$0.001 ordinary shares

Sale

6,475

100.0142  USD

$0.001 ordinary shares

Purchase

4

99.9000  USD

$0.001 ordinary shares

Purchase

63

99.6900  USD

$0.001 ordinary shares

Purchase

557

100.0600  USD

$0.001 ordinary shares

Sale

9

99.7200  USD

$0.001 ordinary shares

Purchase

10,414

99.7349  USD

$0.001 ordinary shares

Sale

613

99.8168  USD

$0.001 ordinary shares

Purchase

21

99.8490  USD

$0.001 ordinary shares

Purchase

364

99.8180  USD

$0.001 ordinary shares

Purchase

14

99.8000  USD

$0.001 ordinary shares

Sale

87

99.8300  USD

$0.001 ordinary shares

Sale

201

99.9098  USD

$0.001 ordinary shares

Purchase

5

99.8660  USD

$0.001 ordinary shares

Purchase

1,786

99.8873  USD

$0.001 ordinary shares

Purchase

135

99.8568  USD

$0.001 ordinary shares

Sale

1

99.9200  USD

$0.001 ordinary shares

Purchase

176

99.8729  USD

$0.001 ordinary shares

Purchase

9

99.8033  USD

$0.001 ordinary shares

Sale

3,027

99.6700  USD

$0.001 ordinary shares

Purchase

10

99.8250  USD

$0.001 ordinary shares

Purchase

8

99.9375  USD

$0.001 ordinary shares

Purchase

2,900

99.6700  USD

$0.001 ordinary shares

Sale

1,453

99.9386  USD

$0.001 ordinary shares

Purchase

35

99.8567  USD

$0.001 ordinary shares

Purchase

1,650

100.0502  USD

$0.001 ordinary shares

Purchase

34

99.8651  USD

$0.001 ordinary shares

Purchase

2,041

100.0441  USD

$0.001 ordinary shares

Sale

3,407

99.8136  USD

$0.001 ordinary shares

Sale

2,801

99.8331  USD

$0.001 ordinary shares

Sale

10,267

99.7024  USD

$0.001 ordinary shares

Sale

15,758

99.7697  USD

$0.001 ordinary shares

Purchase

1,950

100.0700  USD

$0.001 ordinary shares

Purchase

38

99.8878  USD

$0.001 ordinary shares

Purchase

57

99.8431  USD

$0.001 ordinary shares

Purchase

99

99.9595  USD

$0.001 ordinary shares

Purchase

100

99.7500  USD

$0.001 ordinary shares

Sale

466

99.6986  USD

$0.001 ordinary shares

Sale

2,500

99.8165  USD

$0.001 ordinary shares

Sale

200

99.9060  USD

$0.001 ordinary shares

Sale

500

99.8756  USD

$0.001 ordinary shares

Purchase

14

99.8442  USD

$0.001 ordinary shares

Sale

5,716

99.8144  USD

$0.001 ordinary shares

Sale

694

99.8642  USD

$0.001 ordinary shares

Purchase

9

99.8200  USD

$0.001 ordinary shares

Purchase

2,756

99.8123  USD

$0.001 ordinary shares

Sale

649

99.7960  USD

$0.001 ordinary shares

Purchase

28

99.8835  USD

$0.001 ordinary shares

Purchase

211

99.9041  USD

$0.001 ordinary shares

Purchase

10,354

99.7035  USD

$0.001 ordinary shares

Sale

105

99.6985  USD

$0.001 ordinary shares

Sale

899

99.7955  USD

$0.001 ordinary shares

Purchase

2

99.8300  USD

$0.001 ordinary shares

Purchase

2

99.8850  USD

$0.001 ordinary shares

Sale

11

99.8700  USD

$0.001 ordinary shares

Sale

998

99.8088  USD

$0.001 ordinary shares

Sale

400

99.7700  USD

$0.001 ordinary shares

Sale

1,850

100.0700  USD

$0.001 ordinary shares

Sale

400

99.8545  USD

$0.001 ordinary shares

Sale

1,212

99.8313  USD

$0.001 ordinary shares

Purchase

7

99.6985  USD

$0.001 ordinary shares

Purchase

210

99.8723  USD

$0.001 ordinary shares

Sale

2,813

99.8160  USD

$0.001 ordinary shares

Purchase

7

99.8485  USD

$0.001 ordinary shares

Sale

5,510

99.8262  USD

$0.001 ordinary shares

Sale

12,191

99.6710  USD

$0.001 ordinary shares

Purchase

11

99.8400  USD

$0.001 ordinary shares

Purchase

359

100.0657  USD

$0.001 ordinary shares

Sale

294

99.6934  USD

$0.001 ordinary shares

Purchase

19

99.8089  USD

$0.001 ordinary shares

Purchase

698

99.8631  USD

$0.001 ordinary shares

Purchase

12,173

99.6710  USD

$0.001 ordinary shares

Purchase

4

99.8750  USD

$0.001 ordinary shares

Purchase

28

99.8192  USD

$0.001 ordinary shares

Sale

1,850

99.8220  USD

$0.001 ordinary shares

Purchase

12

99.8691  USD

$0.001 ordinary shares

Purchase

17

99.8711  USD

$0.001 ordinary shares

Purchase

2,038

99.8893  USD

$0.001 ordinary shares

Sale

200

99.8321  USD

 

 

 

 

 

 

 

 

(b)

Cash-settled derivative transactions

 

Class of

Product

Nature of dealing

Number of

Price per

relevant

description

 

reference

unit

security

 

 

securities

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(c)

Stock-settled derivative transactions (including options)

 

(i)

Writing, selling, purchasing or varying

 

Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price

 

date

money

relevant

 

selling,

securities

per unit

 

 

paid/

security

 

varying etc

to which

 

 

 

received

 

 

 

option

 

 

 

per unit

 

 

 

relates

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

(ii)

Exercising

 

 

 

 

 

 

Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security

 

 

securities

unit

 

 

 

 

 

 

 

 

 

 

 

 

 

(d)

Other dealings (including subscribing for new securities)

 

Class of relevant

Nature of Dealings

Details

Price per unit (if

security

 

 

applicable)

 

 

 

 

4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding,

 

 

formal or informal, relating to relevant securities which may be an inducement to deal

 

 

or refrain from dealing entered into by the exempt principal trader making the disclosure and any party

 

to the offer or any person acting in concert with a party to the offer:

 

 

 

NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between

 

 

the person making the disclosure and any other person relating to:

 

 

(i)  the voting rights of any relevant securities under any option; or

 

 

 

(ii) the voting rights of future acquisition or disposal of any relevant securities to which

 

 

any derivative is referenced:

 

 

 

 

 

 

NONE

(c)

Attachments

 

 

 

 

 

 

Is a Supplemental Form 8 (Open Positions) attached?

YES

Date of disclosure:

06 Jun 2023

Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

DETAILS OF OPEN OPTION AND DERIVATIVE POSITIONS, AGREEMENTS TO

PURCHASE OR SELL ETC.

Note 5(i) on Rule 8 of the Takeover Code (the "Code")

1.

KEY INFORMATION

Identity of the person whose positions/dealings

Barclays PLC.

are being disclosed:

Name of offeror/offeree in relation to whose

HORIZON THERAPEUTICS PLC

relevant securities this from relates:

 

 

 

 

 

 

 

 

2.

OPTIONS AND DERIVATIVES

Class of relevant security

Product description

Writing, purchasing, selling, varying etc

Number of securities to which option relates

Exercise price per unit

Type

Expiry date

$0.001 ordinary shares

Put Options

Purchased

-544,200

80.0000

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Purchased

-250,000

80.0000

American

16 Jun 2023

$0.001 ordinary shares

Put Options

Purchased

-106,800

90.0000

American

21 Jul 2023

$0.001 ordinary shares

Put Options

Purchased

-10,200

100.0000

American

18 Aug 2023

$0.001 ordinary shares

Call Options

Written

-10,600

105.0000

American

18 Aug 2023

$0.001 ordinary shares

Call Options

Written

-10,000

105.0000

American

16 Jun 2023

$0.001 ordinary shares

Call Options

Written

-2,600

100.0000

American

18 Aug 2023

$0.001 ordinary shares

Call Options

Written

-2,000

100.0000

American

21 Jul 2023

$0.001 ordinary shares

Put Options

Written

2,000

85.0000

American

21 Jul 2023

$0.001 ordinary shares

Put Options

Written

10,200

80.0000

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Written

28,800

95.0000

American

21 Jul 2023

$0.001 ordinary shares

Put Options

Written

74,000

90.0000

American

15 Sep 2023

$0.001 ordinary shares

Put Options

Written

162,000

105.0000

American

21 Jul 2023

$0.001 ordinary shares

Put Options

Written

250,000

105.0000

American

16 Jun 2023

$0.001 ordinary shares

Put Options

Written

400,000

100.0000

American

18 Aug 2023

$0.001 ordinary shares

Put Options

Written

495,500

100.0000

American

16 Jun 2023

 

 

 

 

 

 

 

 

3.

AGREEMENTS TO PURCHASE OR SELL ETC.

Full details should be given so that the nature of the interest or position can be fully understood:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 

Companies

Barclays (BARC)
UK 100

Latest directors dealings